Gladstone NOW: The Campaign Join Us on the Journey ✕
526 - 540 of 1448 Results Clear All
Nautilus—In the ongoing war on cancer, some scientists are taking a new approach—turning on the body’s own self defense system. Assistant Investigator Karin Pelka describes her team’s efforts to train the immune system to recognize and fight tumors.
Gladstone Experts Genomic Immunology Pelka Lab
Scientific American—There is increasing evidence that some people who recover from COVID-19 suffer from lingering heart problems, a phenomenon known as post-COVID-19 cardiac syndrome. Senior Investigator Bruce Conklin explains that it’s important to investigate the long-term consequences of infection, and describes his team’s work showing that infecting heart cells with SARS-CoV-2 can result in dramatic structural damage.
Gladstone Experts COVID-19 Cardiovascular Disease Conklin Lab
San Francisco Chronicle—Associate Investigator Nadia Roan, PhD, comments on a potentially new type of COVID-19 vaccine that would fight the virus at its points of entry—the nose, throat, or lungs—and may provide even better protection than current shots in the arm.
Gladstone Experts COVID-19 Infectious Disease Roan Lab
San Francisco Chronicle—Senior Investigator Warner Greene, MD, PhD, puts the CDC's definition of "fully vaccinated" in the context of our constantly evolving understanding of the COVID-19 pandemic.
Gladstone Experts COVID-19 Center for HIV Cure Research Infectious Disease Greene Lab
Gladstone scientists identified treatments to block subtle epileptic activity and chronic brain inflammation in a mouse model of Alzheimer’s disease
News Release Research (Publication) Alzheimer’s Disease Neurological Disease Mucke Lab
Gladstone virologists discuss the state of the pandemic and how to stay safe this holiday season
COVID-19 Greene Lab Ott Lab
San Francisco Chronicle—Associate Investigator Nadia Roan, PhD, explains that people who receive COVID-19 vaccination after having had the disease harbor special immune cells that may provide stronger and more durable protection against future infections.
Gladstone Experts COVID-19 Infectious Disease Roan Lab
USA Today—Senior investigator Warner Greene, MD, PhD, comments on the benefits of vaccination after COVID-19 illness.
Gladstone Experts COVID-19 Center for HIV Cure Research Infectious Disease Greene Lab
Learn how you and your organization can make sharing pronouns commonplace
People Services LGBTQ Diversity
Gladstone scientists help explain how reducing the protein tau can prevent abnormal brain activity associated with Alzheimer’s disease, autism, and epilepsy
News Release Research (Publication) Alzheimer’s Disease Epilepsy Neurological Disease Mucke Lab
Jane Srivastava, director of Gladstone's Flow Cytometry Core, shares how her interest in science started at a young age and how lasers can be used for more than defeating stormtroopers
Profile Flow Cytometry Core
Lennart Mucke is recognized for his pioneering discoveries in research on Alzheimer’s disease and related disorders
Awards News Release Neurological Disease Mucke Lab
Stanford Medicine News—A Collaboration Between Two Colleagues Seeks to End Research Disparities
Tcheandjieu Lab
ABC7 News—Gladstone President Deepak Srivastava, MD, and Senior Investigator Nevan Krogan, PhD, compare and contrast vaccines to Merck's new drug against COVID-19.
Gladstone Experts COVID-19 Cardiovascular Disease Data Science and Biotechnology Krogan Lab Srivastava Lab
Gladstone researchers studied how T cells respond to COVID-19 vaccines over the weeks following immunization
News Release Research (Publication) COVID-19 Infectious Disease Roan Lab
